UNSPSC 51141598: Zoniclezole hydrochloride

This classification denotes an anticonvulsant agent with the molecular formula C12H10ClN3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0VM256HNOM, chemically known as 1,2-benzisoxazole, 5-chloro-3-(1-(1h-imidazol-1-yl)ethyl)- but more generally known as zoniclezole hydrochloride, which bears US NIH Compound Identifier 60745. Most nations, for tariff and trade purposes, schedule zoniclezole hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, ZONICLEZOLE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

Zoniclezole hydrochloride bears US NLM identifiers UMLS ID C0959127 and NCI Concept Code C82236. SMILES: CC(C1C2CC(CCC2ON1)CL)N3CCNC3.CL.

UNSPSC 51141598 Zoniclezole hydrochloride is a Commodity code that in recent state and local procurement activity does not show solicitations aligned with its nominal pharmaceutical scope. The single recent opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS—requests naloxone and safe drug deactivation systems, products unrelated to zoniclezole hydrochloride. This mismatch suggests either a coding error in the county's procurement system or a temporary classification misalignment, and the code shows no other recent state and local activity to establish a pattern of actual buying behavior.

Without additional opportunities tagged to this code, no meaningful characterization of issuing-body mix, geographic spread, or market activity is supported. Procurement professionals evaluating this code should verify the correct UNSPSC classification for zoniclezole hydrochloride products before committing resources to pursuit, as the single available record does not reflect the code's stated commodity.